🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/04/2001 | 71,56 | 72,47 | 71,09 | 72,19 | +1,07% | 1,93% | 4.171.983 |
| 26/04/2001 | 71,19 | 72,09 | 70,73 | 71,42 | -0,01% | 1,92% | 4.794.600 |
| 25/04/2001 | 70,10 | 71,55 | 69,95 | 71,43 | +1,91% | 2,27% | 4.680.158 |
| 24/04/2001 | 70,85 | 71,56 | 69,70 | 70,10 | -1,06% | 2,63% | 5.098.939 |
| 23/04/2001 | 71,04 | 71,47 | 70,60 | 70,85 | +0,87% | 1,22% | 6.132.896 |
| 20/04/2001 | 72,04 | 72,42 | 68,70 | 70,24 | -5,95% | 5,17% | 16.874.162 |
| 19/04/2001 | 75,12 | 75,35 | 73,86 | 74,69 | -1,30% | 1,99% | 5.655.008 |
| 18/04/2001 | 76,23 | 76,74 | 74,62 | 75,67 | -1,92% | 2,78% | 8.203.115 |
| 17/04/2001 | 74,90 | 77,15 | 74,90 | 77,15 | +2,21% | 3,01% | 4.985.441 |
| 16/04/2001 | 75,86 | 76,74 | 74,90 | 75,48 | -0,50% | 2,42% | 4.578.502 |
| 12/04/2001 | 72,90 | 76,05 | 72,90 | 75,86 | +3,05% | 4,32% | 5.039.622 |
| 11/04/2001 | 73,85 | 73,98 | 73,12 | 73,62 | -1,58% | 1,16% | 5.062.154 |
| 10/04/2001 | 74,90 | 75,09 | 73,95 | 74,80 | +0,50% | 1,52% | 6.191.584 |
| 09/04/2001 | 73,52 | 74,43 | 73,09 | 74,43 | +2,07% | 1,82% | 4.635.304 |
| 06/04/2001 | 71,56 | 73,03 | 70,94 | 72,92 | +0,84% | 2,92% | 4.912.919 |
| 05/04/2001 | 71,07 | 72,41 | 70,62 | 72,31 | +1,75% | 2,52% | 5.350.564 |
| 04/04/2001 | 69,61 | 71,62 | 68,75 | 71,07 | +2,29% | 4,13% | 5.335.473 |
| 03/04/2001 | 70,86 | 72,28 | 69,08 | 69,48 | -1,94% | 4,51% | 6.232.246 |
| 02/04/2001 | 71,95 | 72,51 | 70,19 | 70,85 | -2,17% | 3,22% | 5.306.234 |
| 30/03/2001 | 70,80 | 72,81 | 70,59 | 72,42 | +2,29% | 3,13% | 4.855.698 |
| 29/03/2001 | 70,90 | 73,14 | 69,78 | 70,80 | -1,26% | 4,74% | 5.654.903 |
| 28/03/2001 | 70,13 | 71,91 | 69,71 | 71,71 | +2,09% | 3,13% | 5.089.717 |
| 27/03/2001 | 69,18 | 70,61 | 68,61 | 70,24 | +2,98% | 2,90% | 5.910.615 |
| 26/03/2001 | 66,79 | 68,61 | 66,36 | 68,21 | +3,62% | 3,36% | 5.607.953 |
| 23/03/2001 | 65,70 | 67,41 | 64,60 | 65,82 | -1,05% | 4,28% | 8.962.391 |
| 22/03/2001 | 64,41 | 66,98 | 62,98 | 66,52 | +2,58% | 6,22% | 7.780.562 |
| 21/03/2001 | 66,36 | 66,65 | 64,43 | 64,85 | -3,26% | 3,35% | 6.039.100 |
| 20/03/2001 | 69,17 | 69,22 | 66,84 | 67,03 | -2,53% | 3,44% | 5.551.256 |
| 19/03/2001 | 68,13 | 69,56 | 67,93 | 68,77 | +0,87% | 2,39% | 4.925.705 |
| 16/03/2001 | 69,86 | 70,13 | 67,45 | 68,18 | -3,51% | 3,84% | 10.012.068 |